Unresectable Locally Advanced Pancreatic Cancer: Treatment With Neoadjuvant Leucovorin, Fluorouracil, Irinotecan, and Oxaliplatin and Assessment of Surgical Resectability

被引：9
作者：
Mondo, Esther Liu [1 ]
Noel, Marcus S. [2 ]
Katz, Alan W. [2 ]
Schoeniger, Luke O. [2 ]
Hezel, Aram F. [2 ]
机构：
[1] Univ Rochester, Med Ctr, Sch Med & Dent, Rochester, NY 14627 USA
[2] Univ Rochester, Med Ctr, Sch Med & Dent, James P Wilmot Canc Ctr, Rochester, NY 14642 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 03期
关键词：
CHEMOTHERAPY; GEMCITABINE;
D O I：
10.1200/JCO.2012.44.0339
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：E37 / E39
页数：3
相关论文
共 50 条
  • [21] Effect of Radiotherapy in Neoadjuvant Treatment of Borderline Resectable and Locally Advanced Pancreatic Cancer
    Tang, Peng
    Zhang, Junfeng
    Zhou, Qiang
    Yi, Wenmin
    Wang, Huaizhi
    PANCREAS, 2025, 54 (03) : e246 - e254
  • [22] Prolonged Neoadjuvant Therapy for Locally Advanced Pancreatic Cancer
    Eguchi, Hidetoshi
    Yamada, Daisaku
    Iwagami, Yoshifumi
    Gotoh, Kunihito
    Kawamoto, Koichi
    Wada, Hiroshi
    Asaoka, Tadafumi
    Noda, Takehiro
    Takeda, Yutaka
    Tanemura, Masahiro
    Sakai, Daisuke
    Satoh, Taroh
    Kudo, Toshihiro
    Isohashi, Fumiaki
    Mori, Masaki
    Doki, Yuichiro
    DIGESTIVE SURGERY, 2018, 35 (01) : 70 - 76
  • [23] Neoadjuvant chemotherapy of irinotecan, 5-fluorouracil and leucovorin in patients with advanced rectal cancer. Report of two cases
    Hasegawa, H
    Watanabe, M
    Baba, H
    Yoshinare, K
    Mukai, M
    Kubota, T
    Kitajima, M
    HEPATO-GASTROENTEROLOGY, 2002, 49 (46) : 891 - 893
  • [24] Transarterial infusion with gemcitabine and oxaliplatin for the treatment of unresectable pancreatic cancer
    Chen, Yi
    Wang, Xiao-Lin
    Wang, Jian-Hua
    Yan, Zhi-Ping
    Cheng, Jie-Min
    Gong, Gao-Quan
    Liu, Ling-Xiao
    Li, Guo-Ping
    Li, Chang-Yu
    ANTI-CANCER DRUGS, 2014, 25 (08) : 958 - 963
  • [25] Gemcitabine chemotherapy versus 5-fluorouracil-based concurrent chemoradiotherapy in locally advanced unresectable pancreatic cancer
    Park, Joo Kyung
    Ryu, Ji Kon
    Lee, Jun Kyu
    Yoon, Won Jae
    Lee, Sang Hyub
    Kim, Yong-Tae
    Yoon, Yong Bum
    PANCREAS, 2006, 33 (04) : 397 - 402
  • [26] Predictors for resectability and survival in locally advanced pancreatic cancer after gemcitabine-based neoadjuvant therapy
    Chao, Ying-Jui
    Sy, Edgar D.
    Hsu, Hui-Ping
    Shan, Yan-Shen
    BMC SURGERY, 2014, 14
  • [27] Clinical effects of chemoradiotherapy in pursuit of optimal treatment of locally advanced unresectable pancreatic cancer
    Sui, Kenta
    Okabayashi, Takehiro
    Shima, Yasuo
    Morita, Sojiro
    Iwata, Jun
    Sumiyoshi, Tatsuaki
    Saisaka, Yuichi
    Hata, Yasuhiro
    Noda, Yoshihiro
    Matsumoto, Manabu
    Nishioka, Akihito
    Iiyama, Tastuo
    Shimada, Yasuhiro
    BRITISH JOURNAL OF RADIOLOGY, 2017, 90 (1075)
  • [28] GEMOX plus Tomotherapy for Unresectable Locally Advanced Pancreatic Cancer
    Milandri, Carlo
    Polico, Rolando
    Garcea, Domenico
    Passardi, Alessando
    Gardini, Andrea
    Romeo, Antonin
    Scarpi, Emanuela
    Rosetti, Paola
    Ridolfi, Laura
    La Barba, Giuliano
    Ricci, Marianna
    Amadori, Dino
    HEPATO-GASTROENTEROLOGY, 2011, 58 (106) : 599 - 603
  • [29] A meta-analysis of chemotherapy regimen Fluorouracil/Leucovorin/Oxaliplatin Compared with Fluorouracil/Leucovorin in treating advanced colorectal cancer
    Chen, Mian Ling
    Fang, Chi Hua
    Sen Liang, Liu
    Dai, Li Hua
    Wang, Xiao Kang
    SURGICAL ONCOLOGY-OXFORD, 2010, 19 (01): : 38 - 45
  • [30] Irinotecan or oxaliplatin combined with leucovorin and 5-fluorouracil as first-line treatment in advanced colorectal cancer: a multicenter, randomized, phase II study
    Kalofonos, HP
    Aravantinos, G
    Kosmidis, P
    Papakostas, P
    Economopoulos, T
    Dimopoulos, M
    Skarlos, D
    Bamias, A
    Pectasides, D
    Chalkidou, S
    Karina, M
    Koutras, A
    Samantas, E
    Bacoyiannis, C
    Samelis, GF
    Basdanis, G
    Kalfarentzos, F
    Fountzilas, G
    ANNALS OF ONCOLOGY, 2005, 16 (06) : 869 - 877
12345